|
Market Closed -
Hong Kong S.E.
03:08:10 2026-11-04 EST
|
5-day change | 1st Jan Change | ||
| 147.90 HKD | +3.86% |
|
+3.21% | +8.75% |
| Market Cap | 9.53B 11.21B 1.43B 1.28B 1.17B 1.06B 2B 135B 2.05B 13.99B 5.63B 71.42B 5.36B 5.25B 226B | P/E 2026 * |
53.6x | P/E 2027 * | 52.2x |
|---|---|---|---|---|---|
| Enterprise Value | 9.53B 11.21B 1.43B 1.28B 1.17B 1.06B 2B 135B 2.05B 13.99B 5.63B 71.42B 5.36B 5.25B 226B | EV / Sales 2026 * |
14.1x | EV / Sales 2027 * | 12.3x |
| Free-Float |
29.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +3.86% | ||
| 1 week | +3.21% | ||
| Current month | +6.17% | ||
| 1 month | -11.96% | ||
| 3 months | -20.61% | ||
| 6 months | -41.82% | ||
| Current year | +8.75% |
| 1 week | 138 |  | 148 |
| 1 month | 137.5 | | 168.8 |
| Current year | 125.3 | | 302.4 |
| 1 year | 111 | | 302.4 |
| 3 years | 97.5 | | 302.4 |
| 5 years | 97.5 | | 302.4 |
| 10 years | 97.5 | | 302.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yan Feng
PRN | Corporate Officer/Principal | 51 | 2012-03-26 |
Xin Shan Kang
CEO | Chief Executive Officer | 55 | 2012-03-26 |
Jun Huan Zhang
DFI | Director of Finance/CFO | 56 | 2021-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Xin Shan Kang
CHM | Chairman | 55 | 2017-10-31 |
Yan Feng
BRD | Director/Board Member | 51 | 2017-10-31 |
Guang Ming Chen
BRD | Director/Board Member | 62 | 2023-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.86% | +3.21% | +27.17% | - | 1.43B | |
| -0.11% | +9.94% | +57.20% | +148.21% | 1,255B | |
| -1.62% | -0.95% | +42.90% | +75.88% | 641B | |
| -0.98% | -0.14% | +34.93% | +102.23% | 505B | |
| +0.65% | -1.55% | +48.71% | +65.55% | 381B | |
| -2.49% | +2.01% | +75.38% | +39.94% | 357B | |
| +1.55% | +3.17% | +31.38% | +58.26% | 303B | |
| +1.28% | +8.74% | +10.79% | +35.07% | 286B | |
| -0.90% | +2.97% | +55.67% | +70.93% | 249B | |
| -1.68% | +5.27% | +37.21% | +105.26% | 208B | |
| Average | +1.58% | +2.79% | +42.14% | +77.93% | 418.67B | |
| Weighted average by Cap. | +1.54% | +3.90% | +46.97% | +93.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 678M 797M 102M 90.77M 83.38M 75.72M 142M 9.62B 146M 995M 400M 5.08B 381M 373M 16.1B | 774M 910M 116M 104M 95.18M 86.44M 162M 10.99B 166M 1.14B 457M 5.8B 435M 426M 18.38B |
| Net income | 178M 209M 26.67M 23.83M 21.89M 19.88M 37.33M 2.53B 38.27M 261M 105M 1.33B 100M 97.98M 4.23B | 183M 215M 27.42M 24.5M 22.5M 20.44M 38.38M 2.6B 39.35M 269M 108M 1.37B 103M 101M 4.35B |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-04 | HK$147.90 | +3.86% | 50,250 |
| 26-11-03 | HK$142.40 | +0.92% | 31,250 |
| 26-11-02 | HK$141.10 | +1.29% | 28,000 |
| 26-10-30 | HK$139.30 | -1.21% | 26,950 |
| 26-10-29 | HK$141.00 | -1.61% | 41,250 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
121.11CNY
Average target price
249.61CNY
Spread / Average Target
+106.10%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2637 Stock
Select your edition
All financial news and data tailored to specific country editions
